Table 3 Multivariate analysis
From: Independent prognostic value of fascin immunoreactivity in stage I nonsmall cell lung cancer
Variables | Categories | HR a | 95% CI a | P value |
|---|---|---|---|---|
Adenocarcinomas | ||||
Age | Continuous | 0.97 | 0.94–1.01 | 0.0957 |
Sex | F vs M | 0.39 | 0.13–1.17 | 0.0916 |
Fascin-reactive cells | <5% vs >60% | 4.48 | 1.35–14.9 | 0.0144 |
Tumour grade | G1/G2/G3 | 0.74 | 0.40–1.36 | 0.3303 |
Tumour stage | T1B vs T1A | 1.82 | 0.42–7.83 | 0.4213 |
Tumour diameter | Continuous | 0.79 | 0.17–3.73 | 0.7649 |
Performance status | Continuous | 0.94 | 0.89–0.99 | 0.0233 |
Symptoms | Present vs absent | 2.96 | 1.07–8.22 | 0.0368 |
Vascular invasion | Present vs absent | 1.23 | 0.59–2.57 | 0.5901 |
Ki-67 index | Continuous | 1.01 | 0.99–1.03 | 0.1553 |
Squamous cell carcinomas | ||||
Age | Continuous | 1.02 | 0.98–1.06 | 0.3874 |
Sex | F vs M | 0.79 | 0.18–3.37 | 0.7450 |
Fascina intensity | High vs low | 1.83 | 1.00–3.35 | 0.0516 |
Tumour grade | G1/G2/G3 | 1.02 | 0.57–1.83 | 0.9518 |
Tumour stage | T1B vs T1A | 0.98 | 0.37–2.56 | 0.9612 |
Tumour diameter | Continuous | 1.11 | 0.88–1.40 | 0.3914 |
Performance status | Continuous | 1.01 | 0.97–1.04 | 0.6433 |
Symptoms | Present vs absent | 1.42 | 0.68–2.96 | 0.3562 |
Vascular invasion | Present vs absent | 1.19 | 1.01–3.62 | 0.0481 |
